financetom
Business
financetom
/
Business
/
VF's $1.5 Billion Supreme Brand Sale Is 'Double-Edged Sword,' Wedbush Says
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
VF's $1.5 Billion Supreme Brand Sale Is 'Double-Edged Sword,' Wedbush Says
Jul 17, 2024 9:13 AM

11:57 AM EDT, 07/17/2024 (MT Newswires) -- VF's (VFC) sale of its Supreme brand to EssilorLuxottica for $1.5 billion in cash appears to be a "double-edged sword," Wedbush said Wednesday in a report.

"On the bright side, it will give them much-needed balance sheet flexibility" with the company facing $1.75 billion in debt due in the next nine months, while Supreme was "the most profitable brand in the portfolio," Wedbush said.

"While this deal does relieve the pressure from near-term debt maturities, there's still quite a bit of work to be done to clean up the balance sheet," Wedbush said.

The transaction, expected to close by the end of the year, probably means earnings dilution of $0.20 to $0.23 a share, Wedbush said.

Wedbush raised its price target on VF stock to $13 from $11 with a neutral rating.

VF shares rose 7.7% in recent trading. The Supreme deal was announced earlier Wednesday.

VF shares rose 7.6% in recent trading.

Price: 15.32, Change: +1.10, Percent Change: +7.70

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Jubilant Bhartia Group buys 40% stake in Coca-Cola's Indian bottler
Jubilant Bhartia Group buys 40% stake in Coca-Cola's Indian bottler
Dec 11, 2024
Dec 11 (Reuters) - Jubilant Bhartia Group said on Wednesday it will buy a 40% stake in Hindustan Coca-Cola Beverages, the largest Coca-Cola bottler in India. ...
Myriad Genetics Expects to Reach Resolution With UnitedHealthcare Over Pharmacogenetic Testing Before Yearend
Myriad Genetics Expects to Reach Resolution With UnitedHealthcare Over Pharmacogenetic Testing Before Yearend
Dec 11, 2024
06:13 AM EST, 12/11/2024 (MT Newswires) -- Myriad Genetics ( MYGN ) said late Tuesday that it seeks to reach a resolution with UnitedHealth Group's ( UNH ) UnitedHealthcare on medical policy for pharmacogenetic tests, including Myriad's GeneSight test, before the yearend, but discussions may continue into early next year. We remain steadfast in our confidence in the clinical validity...
Exclusive-Trump tariff plan puts $3 billion in Diageo, Becle tequila imports at risk
Exclusive-Trump tariff plan puts $3 billion in Diageo, Becle tequila imports at risk
Dec 11, 2024
LONDON (Reuters) - Some $3 billion in tequila and mezcal imports from top makers of the popular spirits, Diageo and Jose Cuervo owner Becle, are at risk from U.S. President-elect Donald Trump's planned tariffs on Mexico, according to Mexican customs data reviewed by Reuters. Trump, who takes office on Jan. 20, has said he will slap 25% tariffs on imports...
Intel Downgraded to BBB Rating Over High Industry Costs Amid Management Uncertainty, S&P Says
Intel Downgraded to BBB Rating Over High Industry Costs Amid Management Uncertainty, S&P Says
Dec 11, 2024
06:19 AM EST, 12/11/2024 (MT Newswires) -- Intel ( INTC ) was downgraded to S&P's BBB rating from BBB+ over a slow industry recovery and higher-than-expected manufacturing costs that are expected to last through 2025, the rating agency said Tuesday. Intel's ( INTC ) discretionary cash flow, or DCF, is expected to improve amid the chipmaker's cost-cutting efforts, but its...
Copyright 2023-2026 - www.financetom.com All Rights Reserved